Skip to main content

Jonathan Said, Lawrence F. Bruder, Todd P. Christian, Lalit Dhir, Martin Wells, Applied Biosystems, Gentra Systems, and Epicentre Biotechnologies



Jonathan Said has joined CombiMatrix's wholly owned subsidiary, CombiMatrix Molecular Diagnostics, as a member of its scientific advisory board, Acacia said last week.

On the board, he will provide knowledge in the area of lymphoma molecular pathology.

Said is a board certified anatomic pathologist and is chief of the Division of Anatomic Pathology and chief of Surgical Pathology at the Department of Pathology and Laboratory Medicine at California's UCLA Medical Center for the Health Sciences.

He received his medical degree from the University of Witwatersrand Medical School, Johannesburg, South Africa and completed his pathology residencies at the Mallory Institute of Pathology and Peter Bent Brigham Hospital, Boston, Massachusetts. He completed clinical and research pathology fellowships at Harvard Medical School.

Guava Technologies promoted chief operating officer Lawrence F. Bruder to chief executive officer and added two vice-presidents to the senior management team.

The new vice-president of commercial operations, Todd P. Christian, comes to Guava from Applied Biosystems and BD Biosciences, where he held various positions, including general manager.

The new vice-president of corporate development and strategic marketing, Lalit Dhir, was a vice-president at BD Biosciences and gained management experience at Pharmingen.

Nonlinear Dynamics appointed Martin Wells as international sales manager earlier this week, the company said.

Prior to Nonlinear, Wells spent 13 years in a variety of senior sales and marketing positions at Helena BioSciences.



New Releases

Applied Biosystems last week launched three TaqMan Low Density Array Gene Signature Panels. Gene signature panels are now available for Human GPCR, Human Protein Kinase, and Mouse Immune targets. The company previously offered only Human Immune and Human Endogenous control panels.

According to ABI, the panels work with the firm's 384-well TaqMan Low Density arrays designed for use on its 7900HT Fast Real-Time PCR System.

Gentra Systems last week introduced its VersaGene DNA Cell Purification Kit. The company claims that VersaGene is highly scalable and allows purification of very high quality, double-stranded DNA from as few as 1,000 and up to 25 million cells from the same kit, in as little as 30 minutes.

Gentra recommended the kit for use with SNP microarrays and comparative genomic hybridization microarrays.

Epicentre Biotechnologies this week launched its MasterPure Yeast RNA Purification Kit, which the company claims provides all of the reagents needed to purify RNA from cell types including Candida, Saccharomyces, Schizosaccharomyces, and filamentous fungi.

Epicentre said the kit uses a desalting process to remove contaminating macromolecules, avoiding toxic organic solvents, bead beating, and spheroplasting.

Filed under

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.